Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives
Authors
Keywords
Interleukin-2, Graft-versus-host disease, Regulatory T cell, Immune tolerance
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 107, Issue 2, Pages 130-137
Publisher
Springer Nature
Online
2017-12-12
DOI
10.1007/s12185-017-2386-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
- (2017) Brian C. Betts et al. HAEMATOLOGICA
- Cytokine Signaling in the Development and Homeostasis of Regulatory T cells
- (2017) Kevin H. Toomer et al. Cold Spring Harbor Perspectives in Biology
- IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
- (2017) Brian C. Betts et al. HAEMATOLOGICA
- Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
- (2016) John Koreth et al. BLOOD
- Restoring Regulatory T Cells in Type 1 Diabetes
- (2016) Allyson Spence et al. Current Diabetes Reports
- Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
- (2016) Jing He et al. NATURE MEDICINE
- Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study
- (2016) Xiang-Yu Zhao et al. OncoImmunology
- Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD
- (2015) A. C. Alho et al. BLOOD
- Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
- (2014) A. A. Kennedy-Nasser et al. CLINICAL CANCER RESEARCH
- Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation
- (2014) K. Murase et al. HAEMATOLOGICA
- Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers
- (2014) Sawa Ito et al. MOLECULAR THERAPY
- Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation
- (2014) Atsushi Satake et al. PLoS One
- Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
- (2014) Emeline Castela et al. JAMA Dermatology
- Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells
- (2013) Atsushi Satake et al. JOURNAL OF AUTOIMMUNITY
- Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells
- (2013) Wim Pierson et al. NATURE IMMUNOLOGY
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Cutting Edge: IL-2 Signals Determine the Degree of TCR Signaling Necessary To Support Regulatory T Cell Proliferation In Vivo
- (2012) T. Zou et al. JOURNAL OF IMMUNOLOGY
- Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation
- (2011) Y. Kawano et al. BLOOD
- Response to self antigen imprints regulatory memory in tissues
- (2011) Michael D. Rosenblum et al. NATURE
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation
- (2010) Ken-ichi Matsuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation
- (2009) Emmanuel Zorn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Plasticity of CD4+ T Cell Lineage Differentiation
- (2009) Liang Zhou et al. IMMUNITY
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Homeostasis of Naive and Memory T Cells
- (2008) Charles D. Surh et al. IMMUNITY
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
- (2008) Qizhi Tang et al. IMMUNITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started